Attention Economy


Tuesday, February 22, 2022

Big Pharma and the High Cost of US Healthcare

This Is How Big Pharma Wins
https://nymag.com/intelligencer/2022/02/this-is-how-big-pharma-wins.html
Two years into the pandemic, the industry has evaded reforms a supermajority of voters want.
 
My take:
https://thehill.com/opinion/finance/591995-health-care-and-higher-education-key-drivers-of-long-term-inflation
There is a role for well-thought-out fiscal interventions to boost efficiency and competition in the health care sector. Reforming the U.S. patent system and making the federal government a more effective negotiator that can leverage its role as a large-scale purchaser to attain lower pharmaceutical drug prices are low hanging fruit that can be plucked with bipartisan support if the Big Pharma lobby can be kept at bay.